SOP – Prevention of Cross Contamination, Mix-Ups and Microbial Contamination

1,299.00

This procedure is to ensure that the manufacture of all finished drug products and Active Pharmaceutical Ingredients is accompanied by risk-based approaches and controls which are designed, implemented, maintained and monitored to manage the risk of Cross-Contamination, to a pre-defined, scientifically derived level of acceptability which meets current regulatory agency expectations and ensures patient safety and to prevent Mix-ups and Microbial Contamination

Reviews

There are no reviews yet.

Be the first to review “SOP – Prevention of Cross Contamination, Mix-Ups and Microbial Contamination”